• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国慢性病前瞻性研究(CKB)10个研究地区中,肺功能测定正常但比值降低与死亡率之间的关联,2004 - 2022年

The Association Between Preserved Ratio Impaired Spirometry and Mortality - 10 CKB Study Areas, China, 2004-2022.

作者信息

Ke Yalei, Zhang Xinyi, Sun Dianjianyi, Pei Pei, Du Huaidong, Chen Yiping, Yang Ling, Yang Xiaoming, Wang Kang, Chen Junshi, Chen Zhengming, Lv Jun, Li Liming, Yu Canqing

机构信息

Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China.

Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing, China.

出版信息

China CDC Wkly. 2024 Oct 25;6(43):1120-1125. doi: 10.46234/ccdcw2024.228.

DOI:10.46234/ccdcw2024.228
PMID:39507567
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11534579/
Abstract

WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: China has the world's most significant public health and economic burden of chronic respiratory disease. However, the association between preserved ratio impaired spirometry (PRISm) and mortality risk is unknown.

WHAT IS ADDED BY THIS REPORT?: The PRISm group exhibited a 37% higher risk of all-cause mortality than the normal group, and the risks of death from cardiovascular diseases, neoplasms, respiratory diseases, and infectious and parasitic diseases were also increased in PRISm. Moreover, the presence of respiratory symptoms or disease was associated with an increased risk of mortality in PRISm.

WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICE?: It is imperative to enhance public awareness of PRISm and to implement measures to facilitate the regression of PRISm toward normal lung function.

摘要

关于该主题已知的信息有哪些?:中国是全球慢性呼吸道疾病公共卫生和经济负担最为严重的国家。然而,肺量计测定值保留率受损(PRISm)与死亡风险之间的关联尚不清楚。

本报告新增了哪些内容?:PRISm组全因死亡风险比正常组高37%,PRISm组中心血管疾病、肿瘤、呼吸系统疾病以及感染性和寄生虫病的死亡风险也有所增加。此外,PRISm中出现呼吸道症状或疾病与死亡风险增加相关。

对公共卫生实践有何启示?:必须提高公众对PRISm的认识,并采取措施促进PRISm向正常肺功能回归。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab6/11534579/72a7b4f6e677/ccdcw-6-43-1120-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab6/11534579/72a7b4f6e677/ccdcw-6-43-1120-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dab6/11534579/72a7b4f6e677/ccdcw-6-43-1120-1.jpg

相似文献

1
The Association Between Preserved Ratio Impaired Spirometry and Mortality - 10 CKB Study Areas, China, 2004-2022.中国慢性病前瞻性研究(CKB)10个研究地区中,肺功能测定正常但比值降低与死亡率之间的关联,2004 - 2022年
China CDC Wkly. 2024 Oct 25;6(43):1120-1125. doi: 10.46234/ccdcw2024.228.
2
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.美国成年人中,比值保留型肺通气功能障碍与临床结局的相关性。
JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
3
Association of preserved ratio impaired spirometry with mortality and cardiovascular diseases: a systematic review and meta-analysis.肺功能障碍与死亡率和心血管疾病的关系:系统评价和荟萃分析。
Syst Rev. 2024 Jul 6;13(1):171. doi: 10.1186/s13643-024-02549-6.
4
Different Risks of Mortality and Longitudinal Transition Trajectories in New Potential Subtypes of the Preserved Ratio Impaired Spirometry: Evidence From the English Longitudinal Study of Aging.肺活量比值降低型肺功能受损新潜在亚型的不同死亡风险及纵向转变轨迹:来自英国老龄化纵向研究的证据
Front Med (Lausanne). 2021 Nov 11;8:755855. doi: 10.3389/fmed.2021.755855. eCollection 2021.
5
Risk Factors, Morbidity, and Mortality in Association With Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern: Clinical Relevance of Preserved Ratio Impaired Spirometry and Restrictive Spirometric Pattern.与比值正常的肺功能受损及限制性肺通气模式相关的危险因素、发病率和死亡率:比值正常的肺功能受损及限制性肺通气模式的临床意义
Chest. 2025 Feb;167(2):548-560. doi: 10.1016/j.chest.2024.08.026. Epub 2024 Aug 27.
6
Association between measures of kidney function and preserved ratio impaired spirometry in diabetes: NHANES 2007-2012.糖尿病患者肾功能指标与保留比受损肺功能的相关性:NHANES 2007-2012。
BMJ Open. 2024 Nov 1;14(10):e075955. doi: 10.1136/bmjopen-2023-075955.
7
The Prognostic Performance of Lung Diffusing Capacity in Preserved Ratio Impaired Spirometry: An Observational Cohort Study.肺弥散量在保留比受损肺功能中的预后性能:一项观察性队列研究。
Int J Chron Obstruct Pulmon Dis. 2022 Oct 28;17:2791-2799. doi: 10.2147/COPD.S384074. eCollection 2022.
8
Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.德国肺癌筛查干预研究(LUSI)中的肺功能损害:患病率、症状以及与肺癌风险、肿瘤组织学和全因死亡率的关联
Transl Lung Cancer Res. 2022 Sep;11(9):1896-1911. doi: 10.21037/tlcr-22-63.
9
Association between Comorbidities and Preserved Ratio Impaired Spirometry: Using the Korean National Health and Nutrition Examination Survey IV-VI.共存疾病与比预计受损肺活量比率的相关性:利用韩国国家健康和营养检查调查 IV-VI。
Respiration. 2022;101(1):25-33. doi: 10.1159/000517599. Epub 2021 Jul 28.
10
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.比值保留型阻塞性通气功能障碍的流行情况、危险因素及临床意义:英国生物库队列分析。
Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6. Epub 2021 Nov 2.

引用本文的文献

1
Chest CT imaging for differentiating normal, PRISm, and COPD in comparison with pulmonary function tests.与肺功能测试相比,胸部CT成像用于鉴别正常、PRISm和慢性阻塞性肺疾病。
Radiol Med. 2025 Aug 21. doi: 10.1007/s11547-025-02061-4.

本文引用的文献

1
Mortality risk in patients with preserved ratio impaired spirometry: assessing the role of physical activity.肺功能比正常受损患者的死亡风险:评估体力活动的作用。
QJM. 2024 Jun 25;117(6):436-444. doi: 10.1093/qjmed/hcae010.
2
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis.肺量测定中比预计值受损与死亡率的关联:系统评价和荟萃分析。
Eur Respir Rev. 2023 Nov 1;32(170). doi: 10.1183/16000617.0135-2023. Print 2023 Dec 31.
3
Preserved Ratio Impaired Spirometry in Relationship to Cardiovascular Outcomes: A Large Prospective Cohort Study.
肺量计功能比值保留但肺功能受损与心血管结局的关系:一项大型前瞻性队列研究。
Chest. 2023 Mar;163(3):610-623. doi: 10.1016/j.chest.2022.11.003. Epub 2022 Nov 11.
4
Risks of Mortality and Airflow Limitation in Japanese Individuals with Preserved Ratio Impaired Spirometry.肺活量比值降低的日本个体的死亡风险和气流受限情况
Am J Respir Crit Care Med. 2022 Sep 1;206(5):563-572. doi: 10.1164/rccm.202110-2302OC.
5
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.美国成年人中,比值保留型肺通气功能障碍与临床结局的相关性。
JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
6
Prevalence, risk factors, and clinical implications of preserved ratio impaired spirometry: a UK Biobank cohort analysis.比值保留型阻塞性通气功能障碍的流行情况、危险因素及临床意义:英国生物库队列分析。
Lancet Respir Med. 2022 Feb;10(2):149-157. doi: 10.1016/S2213-2600(21)00369-6. Epub 2021 Nov 2.
7
Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study.COPDGene 研究中保比预计值受损的肺活量测定中的纵向表型和死亡率。
Am J Respir Crit Care Med. 2018 Dec 1;198(11):1397-1405. doi: 10.1164/rccm.201804-0663OC.
8
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.中国慢性阻塞性肺疾病患病率及危险因素研究(CPH 研究):一项全国性横断面研究。
Lancet. 2018 Apr 28;391(10131):1706-1717. doi: 10.1016/S0140-6736(18)30841-9. Epub 2018 Apr 9.
9
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.用于 3-95 岁年龄范围的肺量测定的多民族参考值:全球肺功能 2012 方程。
Eur Respir J. 2012 Dec;40(6):1324-43. doi: 10.1183/09031936.00080312. Epub 2012 Jun 27.
10
China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up.中国慢性病前瞻性研究:方法学、基线特征和长期随访
Int J Epidemiol. 2011 Dec;40(6):1652-66. doi: 10.1093/ije/dyr120. Epub 2011 Sep 21.